An Open-Label, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Induction with Melphalan/HDS Followed by Trifluridine?tipiracil plus Bevacizumab Versus Trifluridine?tipiracil plus Bevacizumab Alone in Patients with Refractory Metastatic Colorectal Cancer with Liver Dominant Disease
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician?s Choice in Subjects with Fibroblast Growth Factor Receptor FGFR altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma FIRST-308